Lygos a winner of inaugural "Consider Corn" Challenge

Lygos a winner of inaugural "Consider Corn" Challenge

The competition spotlights technology to convert corn into bio-renewable chemicals.

ViewPoint Therapeutics Raises $35 Million Series B

ViewPoint Therapeutics Raises $35 Million Series B

ViewPoint's technology prevents and treats cataracts and presbyopia.

QB3's "Pop-Up Institutes" Efficient Way to Tackle Big Challenges

QB3's "Pop-Up Institutes" Efficient Way to Tackle Big Challenges

Our pop-up institute on fibrosis convenes April 26 at UCSF.

QB3@953 changes name to "MBC Biolabs"

QB3@953 changes name to "MBC Biolabs"

The successful QB3 spinout is making the name change as part of a rebranding and expansion.

Zenflow raises $31M

Zenflow raises $31M

Zenflow's technology relieves urinary blockage caused by enlarged prostate. The funding will accelerate progress to market.

Silver Creek Pharmaceuticals Raises up to $20 Million Financing

Silver Creek Pharmaceuticals Raises up to $20 Million Financing

The financing will help the company advance its Smart Growth Factor™ pipeline into the clinic.

Carmot Therapeutics bags $15M for GLP-1R/GIPR agonist

Carmot Therapeutics bags $15M for GLP-1R/GIPR agonist

This will take Carmot's lead Type 2 diabetes drug through clinical proof of concept.

Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR-T Footprint

Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR-T Footprint

Gilead reasons that the companies could treat a broader range of blood and solid cancers.

Carmot and Amgen to identify new therapeutics for Parkinson’s

Carmot and Amgen to identify new therapeutics for Parkinson’s

The firms will leverage Carmot’s Chemotype Evolution lead-identification technology.

Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

 Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

Novel prodrug with unique mechanism of action takes on the opioid crisis